| Active ingredient (INN) | Temozolomide |
|---|---|
| Brand names | Temizole |
| ATC level 5 | L01AX03 |
| ATC level 4 | L01AX |
| Therapeutic category | Auto-created by Therapeutic Goods Administration — Medicine Shortages scraper |
| Controlled substance | No |
| Marketing-authorisation holders | Juno Pharmaceuticals Pty Ltd, Merck Sharp & Dohme Australia Pty Ltd, Mylan Health Pty Ltd, Accord Healthcare Pty Ltd +1 more |
| Registrations on file | 30 |
| Patient information leaflet (PIL) | Not on file |
| Summary of product characteristics (SPC) | Not on file |
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| Juno | 5 mg | — | 🇦🇺 AU | Juno Pharmaceuticals Pty Ltd | Active |
| Juno | 20 mg | — | 🇦🇺 AU | Juno Pharmaceuticals Pty Ltd | Active |
| Juno | 100 mg | — | 🇦🇺 AU | Juno Pharmaceuticals Pty Ltd | Active |
| Juno | 180 mg | — | 🇦🇺 AU | Juno Pharmaceuticals Pty Ltd | Active |
| Juno | 140 mg | — | 🇦🇺 AU | Juno Pharmaceuticals Pty Ltd | Active |
| TEMODAL temozolomide | 5mg | — | 🇦🇺 AU | Merck Sharp & Dohme Australia Pty Ltd | Active |
| TEMODAL temozolomide | 20mg | — | 🇦🇺 AU | Merck Sharp & Dohme Australia Pty Ltd | Active |
| TEMODAL temozolomide | 100mg | — | 🇦🇺 AU | Merck Sharp & Dohme Australia Pty Ltd | Active |
| TEMODAL temozolomide | 140 mg | — | 🇦🇺 AU | Merck Sharp & Dohme Australia Pty Ltd | Active |
| TEMODAL temozolomide | 180 mg | — | 🇦🇺 AU | Merck Sharp & Dohme Australia Pty Ltd | Active |
| TEMODAL temozolomide | 250mg | — | 🇦🇺 AU | Merck Sharp & Dohme Australia Pty Ltd | Active |
| Apotex | 180 mg | — | 🇦🇺 AU | — | Active |
| Juno | 250 mg | — | 🇦🇺 AU | Juno Pharmaceuticals Pty Ltd | Active |
| Temizole | 180 mg | — | 🇦🇺 AU | Mylan Health Pty Ltd | Active |
| Temizole | 140 mg | — | 🇦🇺 AU | Mylan Health Pty Ltd | Active |